[4] Other symptoms may include shortness of breath, feeling faint, a smooth red tongue, pale skin, chest pain, nausea and vomiting, loss of appetite, heartburn, numbness in the hands and feet, difficulty walking, memory loss, muscle weakness, poor reflexes, blurred vision, clumsiness, depression, and confusion
Consulting a healthcare provider before use is essential
Well evaluate your symptoms, review your risk factors, and recommend the best course of actionincluding B12 therapy if indicated
A novel dopamine agonist for the transdermal treatment of Parkinson's disease
Fatty acids may be oxidized, re-esterified, redistributed, or stored in another tissue
The rate of loss accelerates during the dose escalation phase and typically peaks around weeks 16-32 when you reach higher maintenance doses